z-logo
open-access-imgOpen Access
Addition of Palbociclib to Adjuvant Endocrine Therapy Provides No Benefit
Author(s) -
Catlin Nalley
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000721360.06586.4f
Subject(s) - palbociclib , breast cancer , medicine , oncology , adjuvant , adjuvant therapy , endocrine system , cancer , metastatic breast cancer , hormone

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom